Invited Commentary
- PMID: 40839818
- DOI: 10.1097/XCS.0000000000001076
Invited Commentary
References
-
- Bansal VV, Belmont E, Godley FA, et al. Utility of circulating tumor DNA assessment in characterizing recurrence sites after optimal resection for metastatic colorectal cancer. J Am Coll Surg. 2024;238:1013–1020.
-
- Dhiman A, Kothary V, Witmer HDD, et al. Role of tumor-informed personalized ctDNA assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative intent surgery. Ann Surg. 2023;278:925–931.
-
- Xue J, Prabhakaran S, Prabhakaran S, et al. The utility of ctDNA in colorectal cancer with peritoneal metastases. ANZ J Surg. 2023;93:506–509.
-
- Pretzsch E, Bösch F, Neumann J, et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol. 2019;2019:7407190.
-
- Baumgartner JM, Botta GP. Role of circulating tumor DNA among patients with colorectal peritoneal metastases. J Gastrointest Cancer. 2023.
LinkOut - more resources
Full Text Sources